Literature DB >> 1313741

Cytogenetic analysis of 124 prospectively ascertained male germ cell tumors.

E Rodriguez1, S Mathew, V Reuter, D H Ilson, G J Bosl, R S Chaganti.   

Abstract

We report the cytogenetic analysis of 124 adult male germ cell tumors ascertained consecutively at the Memorial Sloan-Kettering Cancer Center between 1988 and 1990. Biopsies from testicular and extragonadal primary and metastatic lesions studied included all histological subtypes of germ cell tumors and cases of malignant transformation. Nonrandom numerical and structural chromosomal abnormalities including i(12p), the previously described characteristic marker of these tumors, were determined, and their frequency was compared between histological subtypes, between gonadal and extragonadal lesions, and between primary and transformed lesions. The frequency and copy number of i(12p) were found to be higher in nonseminomas compared with seminomas. Nonrandom sites of chromosome rearrangements associated with specific histologies comprised 1p32-36 and 7q11.2 in teratomas and 1p22 in yolk sac tumors. Some tumors that underwent malignant differentiation exhibited chromosome changes previously described to be nonrandomly associated with de novo tumors with the same histological characteristics. Cytological evidence of gene amplification in the form of homogeneously staining regions and/or double minutes was detected in 24% of extragonadal lesions, mainly metastatic tumors, suggesting amplification of a gene(s) associated with metastatic progression of these tumors. While a number of previous small cytogenetic series or individual case reports of germ cell tumors identified several of the features of these tumors reported here, this series comprises analysis of the largest group of tumors ascertained consecutively at a single institution, defines the incidence of nonrandom abnormalities in tumor subsets, and addresses their biological significance.

Entities:  

Mesh:

Year:  1992        PMID: 1313741

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  22 in total

Review 1.  Molecular biology of Barrett's adenocarcinoma.

Authors:  B P Wijnhoven; H W Tilanus; W N Dinjens
Journal:  Ann Surg       Date:  2001-03       Impact factor: 12.969

2.  Impact of Teratoma on the Cumulative Incidence of Disease-Related Death in Patients With Advanced Germ Cell Tumors.

Authors:  Samuel A Funt; Sujata Patil; Darren R Feldman; Robert J Motzer; Dean F Bajorin; Joel Sheinfeld; Satish K Tickoo; Victor E Reuter; George J Bosl
Journal:  J Clin Oncol       Date:  2019-06-24       Impact factor: 44.544

3.  Testicular germ cell tumors with sarcomatous components: an analysis of 33 cases.

Authors:  Charles C Guo; Metin Punar; Alejandro Luiña Contreras; Shi-Ming Tu; Louis Pisters; Pheroze Tamboli; Bogdan Czerniak
Journal:  Am J Surg Pathol       Date:  2009-08       Impact factor: 6.394

4.  Spontaneous metastasis in mouse models of testicular germ-cell tumours.

Authors:  J L Zechel; G T MacLennan; J D Heaney; J H Nadeau
Journal:  Int J Androl       Date:  2011-06-09

Review 5.  Testicular carcinoma.

Authors:  A O'Callaghan; G M Mead
Journal:  Postgrad Med J       Date:  1997-08       Impact factor: 2.401

Review 6.  Testicular germ cell tumor genomics.

Authors:  Solomon L Woldu; James F Amatruda; Aditya Bagrodia
Journal:  Curr Opin Urol       Date:  2017-01       Impact factor: 2.309

Review 7.  Interphase cytogenetics on paraffin sections of paediatric extragonadal yolk sac tumours.

Authors:  J Jenderny; E Köster; O Borchers; A Meyer; W Grote; D Harms; U Jänig
Journal:  Virchows Arch       Date:  1996-04       Impact factor: 4.064

8.  Risk-adapted management for patients with clinical stage I non-seminomatous germ cell tumour of the testis.

Authors:  Soner Guney; Nese Guney; Nurettin Cem Sonmez; Erbil Ergenekon
Journal:  Med Oncol       Date:  2008-09-26       Impact factor: 3.064

9.  Allelic deletions in the long arm of chromosome 12 identify sites of candidate tumor suppressor genes in male germ cell tumors.

Authors:  V V Murty; J Houldsworth; S Baldwin; V Reuter; W Hunziker; P Besmer; G Bosl; R S Chaganti
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

10.  A novel 1p36.2 located gene, APITD1, with tumour-suppressive properties and a putative p53-binding domain, shows low expression in neuroblastoma tumours.

Authors:  C Krona; K Ejeskär; H Carén; F Abel; R-M Sjöberg; T Martinsson
Journal:  Br J Cancer       Date:  2004-09-13       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.